Item 9 Labs Corp (INLB)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 17, 15:34
Item 9 Labs Net Income (Quarterly): -5.911M for June 30, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -5.911M |
| March 31, 2023 | -3.417M |
| December 31, 2022 | -3.258M |
| September 30, 2022 | -18.45M |
| June 30, 2022 | -5.470M |
| March 31, 2022 | -3.878M |
| December 31, 2021 | -3.345M |
| September 30, 2021 | -9.046M |
| June 30, 2021 | -0.8339M |
| March 31, 2021 | 0.049M |
| December 31, 2020 | -1.074M |
| September 30, 2020 | -7.139M |
| June 30, 2020 | -1.608M |
| March 31, 2020 | -1.576M |
| December 31, 2019 | -1.950M |
| September 30, 2019 | -7.762M |
| June 30, 2019 | -0.8506M |
| March 31, 2019 | -0.8838M |
| December 31, 2018 | -0.3288M |
| September 30, 2018 | -0.3536M |
| June 30, 2018 | -0.3452M |
| March 31, 2018 | -0.0276M |
| December 31, 2017 | -0.9753M |
| September 30, 2017 | -0.0761M |
| June 30, 2017 | -0.0113M |
| Date | Value |
|---|---|
| March 31, 2017 | -0.0863M |
| December 31, 2016 | -0.0929M |
| September 30, 2016 | -0.6946M |
| June 30, 2016 | -0.4059M |
| March 31, 2016 | -1.629M |
| December 31, 2015 | -0.3959M |
| September 30, 2015 | -1.976M |
| June 30, 2015 | -0.8427M |
| March 31, 2015 | -0.9986M |
| December 31, 2014 | -0.9231M |
| September 30, 2014 | -0.7004M |
| June 30, 2014 | -0.6597M |
| March 31, 2014 | -14.55M |
| December 31, 2013 | -1.169M |
| September 30, 2013 | -1.774M |
| June 30, 2013 | -0.7195M |
| March 31, 2013 | -0.4471M |
| December 31, 2012 | -0.3846M |
| June 30, 2012 | -0.5543M |
| March 31, 2012 | -2.270M |
| December 31, 2011 | -0.0108M |
| September 30, 2011 | -0.0131M |
| June 30, 2011 | -0.8624M |
| March 31, 2011 | -0.5063M |
| December 31, 2010 | -0.0076M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-18.45M
Minimum
Sep 2022
0.049M
Maximum
Mar 2021
-4.442M
Average
-3.345M
Median
Dec 2021
Net Income (Quarterly) Benchmarks
| Humanigen Inc | -4.182M |
| Cannabis Global Inc | -0.4746M |
| Cantabio Pharmaceuticals Inc | 0.343M |
| Affymax Inc | -- |
| Statera BioPharma Inc | -3.349M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 5.022M |
| Total Expenses (Quarterly) | 7.820M |
| EPS Diluted (Quarterly) | -0.06 |
| Gross Profit Margin (Quarterly) | 56.13% |
| Profit Margin (Quarterly) | -117.7% |